Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ForMune
company
About
ForMune is a medical-based company developing therapeutic vaccines and molecules for subsequent license.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €4.40M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ForMune develops therapeutic vaccines based on protein Extra Domain A of fibronectin. ForMune develops molecules for subsequent license to pharmaceutical and marketing companies
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€4.40M
ForMune has raised a total of
€4.40M
in funding over 2 rounds. Their latest funding was raised on
Sep 19, 2012 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 19, 2012 | Series Unknown | €4.40M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ForMune is funded by 1 investors.
Fundación Caja Navarra
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Fundación Caja Navarra
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
